| Literature DB >> 18662377 |
Solomon Mamo1, Arpad Baji Gal, Zsuzsanna Polgar, Andras Dinnyes.
Abstract
BACKGROUND: The surge in the number of gene expression studies and tendencies to increase the quality of analysis have necessitated the identification of stable reference genes. Although rabbits are classical experimental model animals, stable reference genes have not been identified for normalization. The aims of this study were to compare the expression profiles of the widely used reference genes in rabbit oocytes and preimplantation stage embryos, and to select and validate stable ones to use as reference.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18662377 PMCID: PMC2507718 DOI: 10.1186/1471-2199-9-67
Source DB: PubMed Journal: BMC Mol Biol ISSN: 1471-2199 Impact factor: 2.946
Reference genes selected for the study
| Actin, beta, cytoplasmic | X60733 | 2, 16, 17, 35 | |
| Glyceraldehyde-3-phosphate dehydrogenase | NM_001082253 | 2, 16, 17, 35 | |
| Hypoxanthine guanine phosphoribosyl transferase 1 | ENSOCUG00000003186 | 2, 16, 17, 20 | |
| H2A histone family, member Z | ENSOCUG00000001888 | 8, 12 | |
| Ubiquitin | ENSOCUG00000001288 | 20, 34 | |
| Peptidylprolyl isomerase A | ENSOCUG00000016662 | 10, 16, 17 | |
| Eukaryotic translation elongation factor 1 epsilon 1 | ENSOCUG00000012587 | 57, 12 | |
| Polymerase (RNA) II (DNA directed) polypeptide A | ENSOCUG00000017929 | 16 | |
| TATA box binding protein | ENSOCUG00000007979 | 2, 16, 17, 20 | |
| Glucose-6-phosphate dehydrogenase X-linked | ENSOCUG00000007866 | 16, 21 | |
| Beta-2-microglobulin | ENSOCUG00000017117 | 10, 16, 17, 20 | |
| Phosphoglycerate kinase 1 | ENSOCUG00000014726 | 17, 20 | |
| Tyrosin 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | ENSOCUG00000000734 | 2, 34 | |
| POU domain, class 5, transcription factor 1 | NM_001099957 | 32 |
Primer sequences and optimum PCR conditions for amplifying the products
| Gene | Forward (5' to 3') | Product size (bp) | Primer Used (nM) | Annealing Temp (T°) |
| TCCGCCGCCGGCCCACACT | 188 | 0.40 | 60 | |
| CAAGTTCCACGGCACGGTCA | 118 | 0.40 | 68 | |
| ACGTCGAGGACTTGGAAAGGGTGTT | 96 | 0.40 | 68 | |
| AGAGCCGGCTGCCAGTTCC | 85 | 0.20 | 59 | |
| GTGACACCATCGAGAAT | 173 | 0.40 | 60 | |
| TCCAGGGTTTATGTGCCAGGGTG | 137 | 0.30 | 68 | |
| ACCGCAGAAGAGAAAGCCATAG | 190 | 0.50 | 68 | |
| AGCCCGCCTCCACTGACTCC | 88 | 0.40 | 60 | |
| GCTGAATATAATCCCAAGCGGTTTGC | 73 | 0.30 | 68 | |
| AGACTTCTCGGCCCGCACTG | 176 | 0.40 | 68 | |
| GCTCCGTCTTGGGCTTG | 152 | 0.33 | 60 | |
| TGTTGGTCGGGCGAAGCAG | 149 | 0.50 | 60 | |
| GGTCTGGCCCTTAACTTCTCTGTGTTCTA | 142 | 0.50 | 68 | |
| CGAGTGAGAGGCAACTTGG | 125 | 0.45 | 57 |
Standard curve parameters for the candidate reference genes
| Genes | Slope (m) | Intercept (b) | Efficiency (E) | Correlation (R2) |
| -3.37 | 21.90 | 98.0 | 97.9 | |
| -3.43 | 18.58 | 97.7 | 99.4 | |
| -3.25 | 22.56 | 103.1 | 98.9 | |
| -3.52 | 18.85 | 92.3 | 99.4 | |
| -3.51 | 16.07 | 92.6 | 99.7 | |
| -3.48 | 20.50 | 94.0 | 97.2 | |
| -3.09 | 23.69 | 110.7 | 99.2 | |
| -3.38 | 22.10 | 97.7 | 96.3 | |
| -3.51 | 16.89 | 92.8 | 99.4 | |
| -3.42 | 20.09 | 96.0 | 98.9 | |
| -3.83 | 17.32 | 82.4 | 99.8 |
Figure 1Relative expression levels of selected candidate reference genes in the The expression level at the oocyte stage was taken as a reference to calculate the relative levels of the other stages. Stages with different letters are significantly (P ≤ 0.05) different for the levels of the gene.
Figure 2Relative expression levels of selected candidate reference genes in the The expression level at the oocyte stage was taken as a reference to calculate the relative levels of the other stages. Stages with different letters are significantly (P ≤ 0.05) different for the levels of the gene. An asterisk (*) indicates significant differences {(* = P ≤ 0.05) and (** = P ≤ 0.01)} with the in vivo levels of the same stage.
Figure 3Average gene expression stability values of the candidate reference genes in the in vivo derived and in vitro produced embryo samples as calculated by geNorm software and ranking made based on the relative stability values.
Figure 4Relative expression levels of the The expression at the oocyte stage was taken as a reference to calculate the relative levels of the other stages. Stages with different letters are significantly (P ≤ 0.05) different for the levels of the gene.